Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

IPHA

Innate Pharma SA

CIK 0001598599 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$1.79
↓ 0.05 (-2.72%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BearishOverall score · based on 2/4 lenses
FundamentalsOwnershipTechnicalsOptions

Risks: Ownership; Excluded: Fundamentals, Options (no data)

Key stats

Market Cap
$167.76M
P/E Ratio
Not covered
EPS
-0.55
Dividend Yield
Not covered
52W Position
42%
Beta
1.53

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
Not covered
P/S
Not covered
EV/Revenue
Not covered
ROE
Not covered
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 42%
$1.17$2.63

Latest Financials

2025-12-31 FY
Revenue
$9.01M
Net Income
-$49.18M
Total Assets
$62.72M
Free Cash Flow
-$52.90M

Recent news